4//SEC Filing
Mahal Jeetinder Singh 4
Accession 0001213900-24-108551
CIK 0001788028other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 8:02 PM ET
Size
8.9 KB
Accession
0001213900-24-108551
Insider Transaction Report
Form 4
Mahal Jeetinder Singh
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-12-12+900→ 13,772 totalExercise: $7.10Exp: 2030-05-31→ Voting Common Stock (900 underlying) - Sale
Voting Common Stock
2024-12-12$22.11/sh−900$19,899→ 25,009 total - Exercise/Conversion
Voting Common Stock
2024-12-12$7.10/sh+900$6,390→ 25,909 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.
- [F2]25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001882877
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 8:02 PM ET
- Size
- 8.9 KB